SlideShare a Scribd company logo
1 of 31
Download to read offline
Drug schedules
• Therapeutic goods in the United States are
regulated by the U.S. Food and Drug
Administration (FDA), which makes some
drugs available over the counter at retail
outlets and others by prescription only.
Each of the controlled substances is identified
under one of five Controlled Substances
Schedules.
■ Schedule I
■ Schedule II
■ Schedule III
■ Schedule IV
■ Schedule V
• Schedule I Drugs –
• High potential for abuse.
• No accepted medical use in the U.S. or lacks
accepted safety for use in treatment in the U.S.
• –May be used for research purposes by
properly registered individuals.
• Examples: heroin, methylene
dioxymethamphetamine, lysergic acid
diethylamide, mescaline, and all salts and
isomers thereof
 Schedule II Drugs
 High potential for abuse.
 Has a currently accepted medical use in the
U.S.
 Abuse of substance may lead to severe
psychological or physical dependence.
 Examples: morphine, oxycodone, fentanyl,
meperidine, dextroamphetamine, cocaine,
amobarbital
• Schedule III Drugs
• Abuse potential less than substances in
schedule I or schedule
• Has a currently accepted medical use in the
U.S.
• Abuse of substance may lead to moderate to
low physical dependence or high psychological
dependence.
• Examples: anabolic steroids, nalorphine,
ketamine, certain schedule II substances in
suppositories, mixtures, or limited amounts per
dosage unit
 Schedule IV Drugs –
 Abuse potential less than substances in
schedule III.
 Has a currently accepted medical use in the
U.S.
 Abuse of substance may lead to limited
physical or psychological dependence relative
to substances in schedule III.
 Examples: alprazolam, phenobarbital,
meprobamate, modafinil
INDIAN SCHEDULES:
• Schedule A
• Gives the specimens of prescribed forms necessary for obtaining
licenses, permits, certificates, intimations and so on.
• FORM 2A- Certificate of test or analysis from the Pharmacopoeial
Laboratory for Indian Medicine or Government Analyst
• FORMS 3-7- (Omitted)
• FORM 8 -Application for licence to import drugs –biological and
other special products (excluding those specified in Schedule X) to
the Drugs and Cosmetics Rules, 1945
• FORM 9 - Form of undertaking to accompany an application for
an import license
• FORM 46- Permission / Approval for manufacture of new drug
formulation
• ■There are in total upto 50 forms.
Schedule B
• This Schedule includes fees for test or analysis by the
Central Drug Laboratory or the Government Analyst.
1. Fees for test and assay of Drugs requiring use of
animals – Eg:- Adrenocorticotrophic hormone assay-
1000 Rs
2. Microbiological tests and assays – Eg:- Microbiological
assay of vitamins - 300 Rs
Schedule B(1)
Fees for the test or analysis by the Pharmacopoeial
Laboratory for Indian Medicine (PLIM) or the
Government analyst
Eg:- Determination of lethal does LD 50 to 10 on mice –
2500 Rupee
• Schedule C:-
• Includes biological and special products such as
Sera, Vaccines, Antigens,Toxin, Antitoxin, Insulin,
Bacteriophages, solution of serum proteins
intended for injection, etc.
• Schedule C1:-
• Includes Other Special products such as Digitalis
Preparations, fish liver oil, ergot preparations,
Liver extract, vitamins, hormones, etc.
■Labelled with the words-- „Caution: It is dangerous
to take this preparation except under medical
supervision‟.
■ Prohibition of import of these products after expiry
of potency
Schedule D
• Provides extent and conditions of exemption regarding
import of drugs.
Eg:- Class of drugs which are substances not intended for
medicinal use
• If the substance is imported in bulk, the importer should
certify that the substance is imported for non-medicinal
uses, and
• If imported otherwise than in bulk, each container should
bear a label indicating that the substance is not intended for
medicinal use or is intended for some purposes other than
medicinal use.
• E.g. Skimmed milk, powdered milk fortified with vitamins,
Lactose, cereal products, oats, ginger, pepper, cummins, etc.
come under this class of drugs.
• Shedule DI- permission for manufacture and DII-
permission for import.
• Schedule E
Omitted as per GOI Notification
• Schedule E (I):-
List of poisonous substances under the Ayurvedic
(including Siddha) and Unani Systems of
Medicine : Ayurvedic System:-
■ Drugs of Vegetable origin :- Bhang, Dhatura,
Jaiphala, etc
■ Drugs of Animal origin :- Snake Poison
■ Drugs of Mineral origin :- Hartala (arsenic),
Parada (mercury), etc.
Schedule F
 It includes requirements for the Functioning
and operation of a blood bank and / or for
preparation of blood components.
 General :- Blood bank location, infrastructure
requirements, Staff and equipments required,
etc.
 Minimum requirement for grant of license to
procure blood components from whole human
blood.
 F (I) :- Give details of the standards of bacterial
vaccines, antisera and diagnostic antigens.
 F (II):- Standards for Surgical Dressings that
include bandage cloth, absorbent gauze, rolled
bandage,etc.
 F (III):- Standards For Umbilical Tapes like
umbilical polyester tape, cotton tape, etc.
• Schedule FF
It lays down Standards for Ophthalmic preparations.
Ophthalmic Solutions and suspensions.
1. sterile when dispensed
2. contain suitable substances to prevent the growth of
micro-organisms
3. free from foreign matter & in bottles made of either
neutral glass or soda glass.
4. Label Contains:- „Use the solution within one month
after opening the container‟.
The words „NOT FOR INJECTION‟.
WARNING:- “ Do not touch the dropper tip or other
dispensing tip to any surface since this may
contaminate solutions”.
• Schedule G
• Medicines listed as schedule G medicines carry on the
label a caution
• Caution – “it is dangerous to take this preparation
except under medical supervision”
• The Caution is conspicuously printed and surrounded
by a line within which there should be no other words.
• It is necessary to make proper bill of sale.
• Records of purchase and sale of these medicines must
be maintained for a period of 2 years.
• Eg: Aminopterin, L-Asparaginase, Bleomycin,
Busulphan, Chlorambucil, Chlorthiazide,
Glibenclamide, Hydantoin, Hydroxyurea, Insulin,
Metformin, etc.
• Schedule H
• This Schedule includes PRESCRIPTION DRUGS i.e.
Drugs and Medicines which must be sold by retail only
when a prescription by RMP is produced.
• The time and date of prescription must be noted.
• The drug label must display the texts "Rx" and
"Schedule H drug.
• Warning : To be sold by retail on the prescription of a
Registered Medical practitioner only" prominently.
• Drugs specified in Schedule H, and comes within
{Narcotic Drugs and Psychotropic Substances Act,
1985} labelled with the symbol “NRx” & Schedule H
drug Warning prominently.
• Eg:-Abxicimab, Acyclovir, Diclofenac, Baclofen,
Carbidopa, Terazosin, etc.
• Schedule H1
• Introduced under the Drugs and Cosmetics (4th
amendment ) rules 2013, to regulate sale of antibiotics.
• To have separate regulation to check unauthorized sale
of antibiotics, thus monitoring use and abuse of these
antibiotics.
• Here, the drug has to be labelled with symbol “Rx” in
red and conspicuously displayed on left corner of the
label with the following words in box with red border
• Warning 1. It is dangerous to take this preparation
except in accordance with the medical advice.
• 2 Not to be sold by retail without the prescription of a
RMP.
• Eg:-Gemifloxacin, Cefixime, Levofloxacin,
Cefpodoxime, Clofazimine, Zolpidem, etc
• Schedule I
• Particulars as to proportion of poison in certain
cases.
• Omitted by GOI Notification .
Schedule J
• Contains a list of various diseases and conditions
which a drug may not purport to prevent or cure
or make claims to prevent or cure.
• No drug may legally claim to treat these diseases.
Eg :-AIDS, Blindness, Deafness, Encephalitis,
Diabetes, Leukemia, Paralysis, etc.
Schedule- K
• Drugs exempted from certain provisions relating to the
manufacture and sale of drugs
• Currently, non drug-licensed stores (e.g. non-
pharmacists) can sell a few medicines classified as
„Household Remedies‟ listed in Schedule K.
• Eg- Paracetamol tablets, Analgesic Balms, Antacid
Preparations, Calcium preparations with or
without Vitamin D, Gripe Water for use of infants,
Inhalers (containing drugs for treatment of cold
and nasal congestion), Syrups lozenges, pills and
tablets for cough, cold or sore throat.
• Schedule L :-
• Omitted Schedule L
• Good Laboratory Practices and requirements of
premises and equipments, Chemicals & Reagents,
etc.
Schedule M
This Schedule includes Good Manufacturing Practices
and requirements of premises, plant and
equipment for manufacture of pharmaceutical
products.
■ Part 1 :-Good Manufacturing Practices for premises
and materials.
 Part 2 :- Requirements of Plant and equipments
 M- I:- Prescribes in detail requirements of
factory premises for the manufacture of
Homeopathic drugs.
 M- II:- Prescribes requirements of factory
premises for manufacture of cosmetics.
 M- III:- Prescribes requirements of factory
premises for manufacture of medical devices.
• Schedule N
List of minimum equipment for the efficient running of a
pharmacy
Gives directions to Pharmacies regarding:-
a) Entrance of Pharmacy
b) b) Premises
c) c) Furniture & Apparatus
d) d) General Provisions.
Schedule O
Deals with the provisions applicable to disinfectant fluids.
• Part 1:- Provisions applicable to black and white fluids
Part 2:- Provisions applicable to Other Disinfectants.
Schedule P
• It deals with life period of drug and the
conditions of the storage of drugs.
• Period in months (unless otherwise specified)
between date of manufacture and date of
expiry
• ampicillin- stable for 36 month and store in
cool place
• Schedule P1
• specifies the pack size of certain drugs
• Aspirin (Low Dose) Tablets 14 Tabs per pack.
• Schedule Q
• Gives the list of dyes, colors and pigments
permitted to be used in cosmetics and soaps.
• No drug should contain a colors other than
specified by the Bureau of Indian Standards
below :
(1) Natural Colors:- Carotene, Chlorophyll, Red
Oxide of Iron, Yellow Oxide of Iron, Titanium
Di-oxide, Black Oxide of iron
(2) Artificial Colors:-Caramel
(3) Coal Tar Colors
• Schedule R
• Standards for mechanical contraceptives.
• Eg. Cu-T, etc
• Label contain:- – The date of manufacture.
• – The date up to which the contraceptive is expected to
retain its properties.
Schedule R1
• Standards for medical devices.
The following medical device shall conform to the Indian
Standards specification laid down from time to time by the
Bureau of Indian Standards: -
1. Sterile Disposable Perfusion sets for single use only
2. Sterile Disposable Hypodermic Syringes for single use only
3. Sterile Disposable Hypodermic Needles for single use only
Schedule S
 Prescribes Standard for Cosmetics
 The following cosmetics in finished form
should conform to the specifications laid down
from time to time by the Bureau of Indian
Standards (BIS).
Skin Powders , Tooth Powder, Toothpaste
,Shaving Creams, Hair Creams.
Schedule T
 Lays down the Good Manufacturing Practices
for Ayurvedic, Siddha and Unani Medicines
 PART I:- Good manufacturing practices.
 PART II:- List of recommended machinery,
equipment and minimum manufacturing
premises required for the manufacture of
various categories of ayurvedic, siddha system
of medicines.
Schedule U & U1
• Gives the particulars to be shown in
manufacturing records.
• Gives the particulars to be recorded of raw
materials.
• Gives the particulars to be recorded in analytical
records.
• The records or registers shall be retained for a
period of 5 years for Drugs & 3 years for Cosmetics
from the date of manufacture
Schedule V
• Give details of standards for patent and
proprietary medicines.
Schedule W
 Inserted as per G.O.I in 1981 and deleted IN
2000.
 Gives the name of the drugs which shall be
marketed under generic names only.
 Its label contain the Names and quantities of
active ingredients.
• Schedule X
• Contains list of narcotic drugs and psychotropic substance.
• Have a warning mentioned on a label „Schedule X drug‟ -
Warning : to be sold on retail on prescription of a RMP only.
• The label will also have a symbol „NRx‟ in red &
conspicuously displayed on the top left corner.
• After dispending the drug the pharmacist must Stamp &
retain the prescription for 2 years.
• Maintain & record purchase & sale of the drug and
preserve it for a period of 2 years from the date of
transactions.
• All the regulations of Schedule H apply. The drugs must be
kept under lock and key.
• Examples of few drugs under schedule X :- Phencyclidine,
Secobarbital, Amobarbital, Amphetamines, Glutethimide,
Methylphenidate, etc.
Schedule Y
• This Schedule includes requirements and guidelines
for permission to import and / or manufacture of new
drugs for sale or to undertake clinical trials It include:
• Application for permission
• Clinical trial:-
 Approval for trial
 Responsibilities of sponsor, investigator, Ethics
Committee
 Phases I, II, III, IV
 Studies in special population like Geriatric, Pediatric
and Pregnant/ Nursing women
 Post Marketing Surveillance

More Related Content

What's hot (20)

Pharmacy and Therapeutic committee
Pharmacy and Therapeutic committeePharmacy and Therapeutic committee
Pharmacy and Therapeutic committee
 
Drugs and cosmetics act 1940 and rules 1945
Drugs and cosmetics act 1940 and rules 1945Drugs and cosmetics act 1940 and rules 1945
Drugs and cosmetics act 1940 and rules 1945
 
Code of Pharmaceutical Ethics
Code of Pharmaceutical EthicsCode of Pharmaceutical Ethics
Code of Pharmaceutical Ethics
 
OTC MEDICATIONS
OTC MEDICATIONSOTC MEDICATIONS
OTC MEDICATIONS
 
Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940Drugs and Cosmetics act, 1940
Drugs and Cosmetics act, 1940
 
Dpco
DpcoDpco
Dpco
 
Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955Medicinal and toilet preparation act 1955
Medicinal and toilet preparation act 1955
 
drug inspector
drug inspectordrug inspector
drug inspector
 
Drug price control order 2013
Drug price control order 2013Drug price control order 2013
Drug price control order 2013
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
Tablet Evaluation
Tablet EvaluationTablet Evaluation
Tablet Evaluation
 
Drug schedules
Drug schedulesDrug schedules
Drug schedules
 
Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)
 
State pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy councilState pharmacy council and joint state pharmacy council
State pharmacy council and joint state pharmacy council
 
Bonded vs non bonded laboratories
Bonded vs non bonded laboratoriesBonded vs non bonded laboratories
Bonded vs non bonded laboratories
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Parentrals
ParentralsParentrals
Parentrals
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Capsules
CapsulesCapsules
Capsules
 
Drug distribution in hospital pharmacy
Drug distribution in hospital pharmacyDrug distribution in hospital pharmacy
Drug distribution in hospital pharmacy
 

Similar to Schedules of drugs

Drug regulation
Drug regulationDrug regulation
Drug regulationVenuDDon
 
Drug regulation
Drug regulationDrug regulation
Drug regulationVenuDDon
 
Drug regulation
Drug regulationDrug regulation
Drug regulationVenuDDon
 
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptxDRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptxPrashantKishorRokade
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxDiwakar Sudhakar Shukla
 
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptxPharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptxSagarpamu123
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
 
Drugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rulesDrugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rulesRavish Yadav
 
35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB ExamRxTechExam
 
Drugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IVDrugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IVPranay Sethiya
 
Drugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swaDrugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swaSuvarta Maru
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxPharmacy
 
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for TelemedicinePharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for TelemedicineDr Pankaj Kumar Gupta
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in IndiaChandra Mohan
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Marwah Zagzoug, PhD
 
schedules-170306164609.pptx
schedules-170306164609.pptxschedules-170306164609.pptx
schedules-170306164609.pptxSapnaMahant
 
Herbal drug regulations and standardisation
Herbal drug regulations and standardisationHerbal drug regulations and standardisation
Herbal drug regulations and standardisationRavish Yadav
 

Similar to Schedules of drugs (20)

Drug regulation
Drug regulationDrug regulation
Drug regulation
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptxDRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
 
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptxPharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
 
Drugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rulesDrugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rules
 
35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam
 
Drugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IVDrugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IV
 
Community pharmacy sjk
Community pharmacy sjkCommunity pharmacy sjk
Community pharmacy sjk
 
Drugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swaDrugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swa
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptx
 
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for TelemedicinePharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201
 
D & C Act 1940
D & C Act 1940D & C Act 1940
D & C Act 1940
 
schedules-170306164609.pptx
schedules-170306164609.pptxschedules-170306164609.pptx
schedules-170306164609.pptx
 
The drug and cosmetic act and rules
The drug and cosmetic act and rulesThe drug and cosmetic act and rules
The drug and cosmetic act and rules
 
Herbal drug regulations and standardisation
Herbal drug regulations and standardisationHerbal drug regulations and standardisation
Herbal drug regulations and standardisation
 

More from Suvarta Maru

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus Suvarta Maru
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )Suvarta Maru
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discoverySuvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drugSuvarta Maru
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trialsSuvarta Maru
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatmentSuvarta Maru
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDYSuvarta Maru
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDYSuvarta Maru
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)Suvarta Maru
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)Suvarta Maru
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 

More from Suvarta Maru (20)

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
 
US FDA
US FDA US FDA
US FDA
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Stroke study
Stroke studyStroke study
Stroke study
 
Schedule m
Schedule  m Schedule  m
Schedule m
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
New drug approval
New drug approvalNew drug approval
New drug approval
 

Recently uploaded

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 

Recently uploaded (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 

Schedules of drugs

  • 2. • Therapeutic goods in the United States are regulated by the U.S. Food and Drug Administration (FDA), which makes some drugs available over the counter at retail outlets and others by prescription only. Each of the controlled substances is identified under one of five Controlled Substances Schedules. ■ Schedule I ■ Schedule II ■ Schedule III ■ Schedule IV ■ Schedule V
  • 3. • Schedule I Drugs – • High potential for abuse. • No accepted medical use in the U.S. or lacks accepted safety for use in treatment in the U.S. • –May be used for research purposes by properly registered individuals. • Examples: heroin, methylene dioxymethamphetamine, lysergic acid diethylamide, mescaline, and all salts and isomers thereof
  • 4.  Schedule II Drugs  High potential for abuse.  Has a currently accepted medical use in the U.S.  Abuse of substance may lead to severe psychological or physical dependence.  Examples: morphine, oxycodone, fentanyl, meperidine, dextroamphetamine, cocaine, amobarbital
  • 5. • Schedule III Drugs • Abuse potential less than substances in schedule I or schedule • Has a currently accepted medical use in the U.S. • Abuse of substance may lead to moderate to low physical dependence or high psychological dependence. • Examples: anabolic steroids, nalorphine, ketamine, certain schedule II substances in suppositories, mixtures, or limited amounts per dosage unit
  • 6.  Schedule IV Drugs –  Abuse potential less than substances in schedule III.  Has a currently accepted medical use in the U.S.  Abuse of substance may lead to limited physical or psychological dependence relative to substances in schedule III.  Examples: alprazolam, phenobarbital, meprobamate, modafinil
  • 7. INDIAN SCHEDULES: • Schedule A • Gives the specimens of prescribed forms necessary for obtaining licenses, permits, certificates, intimations and so on. • FORM 2A- Certificate of test or analysis from the Pharmacopoeial Laboratory for Indian Medicine or Government Analyst • FORMS 3-7- (Omitted) • FORM 8 -Application for licence to import drugs –biological and other special products (excluding those specified in Schedule X) to the Drugs and Cosmetics Rules, 1945 • FORM 9 - Form of undertaking to accompany an application for an import license • FORM 46- Permission / Approval for manufacture of new drug formulation • ■There are in total upto 50 forms.
  • 8. Schedule B • This Schedule includes fees for test or analysis by the Central Drug Laboratory or the Government Analyst. 1. Fees for test and assay of Drugs requiring use of animals – Eg:- Adrenocorticotrophic hormone assay- 1000 Rs 2. Microbiological tests and assays – Eg:- Microbiological assay of vitamins - 300 Rs Schedule B(1) Fees for the test or analysis by the Pharmacopoeial Laboratory for Indian Medicine (PLIM) or the Government analyst Eg:- Determination of lethal does LD 50 to 10 on mice – 2500 Rupee
  • 9. • Schedule C:- • Includes biological and special products such as Sera, Vaccines, Antigens,Toxin, Antitoxin, Insulin, Bacteriophages, solution of serum proteins intended for injection, etc. • Schedule C1:- • Includes Other Special products such as Digitalis Preparations, fish liver oil, ergot preparations, Liver extract, vitamins, hormones, etc. ■Labelled with the words-- „Caution: It is dangerous to take this preparation except under medical supervision‟. ■ Prohibition of import of these products after expiry of potency
  • 10. Schedule D • Provides extent and conditions of exemption regarding import of drugs. Eg:- Class of drugs which are substances not intended for medicinal use • If the substance is imported in bulk, the importer should certify that the substance is imported for non-medicinal uses, and • If imported otherwise than in bulk, each container should bear a label indicating that the substance is not intended for medicinal use or is intended for some purposes other than medicinal use. • E.g. Skimmed milk, powdered milk fortified with vitamins, Lactose, cereal products, oats, ginger, pepper, cummins, etc. come under this class of drugs. • Shedule DI- permission for manufacture and DII- permission for import.
  • 11. • Schedule E Omitted as per GOI Notification • Schedule E (I):- List of poisonous substances under the Ayurvedic (including Siddha) and Unani Systems of Medicine : Ayurvedic System:- ■ Drugs of Vegetable origin :- Bhang, Dhatura, Jaiphala, etc ■ Drugs of Animal origin :- Snake Poison ■ Drugs of Mineral origin :- Hartala (arsenic), Parada (mercury), etc.
  • 12. Schedule F  It includes requirements for the Functioning and operation of a blood bank and / or for preparation of blood components.  General :- Blood bank location, infrastructure requirements, Staff and equipments required, etc.  Minimum requirement for grant of license to procure blood components from whole human blood.
  • 13.  F (I) :- Give details of the standards of bacterial vaccines, antisera and diagnostic antigens.  F (II):- Standards for Surgical Dressings that include bandage cloth, absorbent gauze, rolled bandage,etc.  F (III):- Standards For Umbilical Tapes like umbilical polyester tape, cotton tape, etc.
  • 14. • Schedule FF It lays down Standards for Ophthalmic preparations. Ophthalmic Solutions and suspensions. 1. sterile when dispensed 2. contain suitable substances to prevent the growth of micro-organisms 3. free from foreign matter & in bottles made of either neutral glass or soda glass. 4. Label Contains:- „Use the solution within one month after opening the container‟. The words „NOT FOR INJECTION‟. WARNING:- “ Do not touch the dropper tip or other dispensing tip to any surface since this may contaminate solutions”.
  • 15. • Schedule G • Medicines listed as schedule G medicines carry on the label a caution • Caution – “it is dangerous to take this preparation except under medical supervision” • The Caution is conspicuously printed and surrounded by a line within which there should be no other words. • It is necessary to make proper bill of sale. • Records of purchase and sale of these medicines must be maintained for a period of 2 years. • Eg: Aminopterin, L-Asparaginase, Bleomycin, Busulphan, Chlorambucil, Chlorthiazide, Glibenclamide, Hydantoin, Hydroxyurea, Insulin, Metformin, etc.
  • 16. • Schedule H • This Schedule includes PRESCRIPTION DRUGS i.e. Drugs and Medicines which must be sold by retail only when a prescription by RMP is produced. • The time and date of prescription must be noted. • The drug label must display the texts "Rx" and "Schedule H drug. • Warning : To be sold by retail on the prescription of a Registered Medical practitioner only" prominently. • Drugs specified in Schedule H, and comes within {Narcotic Drugs and Psychotropic Substances Act, 1985} labelled with the symbol “NRx” & Schedule H drug Warning prominently. • Eg:-Abxicimab, Acyclovir, Diclofenac, Baclofen, Carbidopa, Terazosin, etc.
  • 17. • Schedule H1 • Introduced under the Drugs and Cosmetics (4th amendment ) rules 2013, to regulate sale of antibiotics. • To have separate regulation to check unauthorized sale of antibiotics, thus monitoring use and abuse of these antibiotics. • Here, the drug has to be labelled with symbol “Rx” in red and conspicuously displayed on left corner of the label with the following words in box with red border • Warning 1. It is dangerous to take this preparation except in accordance with the medical advice. • 2 Not to be sold by retail without the prescription of a RMP. • Eg:-Gemifloxacin, Cefixime, Levofloxacin, Cefpodoxime, Clofazimine, Zolpidem, etc
  • 18. • Schedule I • Particulars as to proportion of poison in certain cases. • Omitted by GOI Notification . Schedule J • Contains a list of various diseases and conditions which a drug may not purport to prevent or cure or make claims to prevent or cure. • No drug may legally claim to treat these diseases. Eg :-AIDS, Blindness, Deafness, Encephalitis, Diabetes, Leukemia, Paralysis, etc.
  • 19. Schedule- K • Drugs exempted from certain provisions relating to the manufacture and sale of drugs • Currently, non drug-licensed stores (e.g. non- pharmacists) can sell a few medicines classified as „Household Remedies‟ listed in Schedule K. • Eg- Paracetamol tablets, Analgesic Balms, Antacid Preparations, Calcium preparations with or without Vitamin D, Gripe Water for use of infants, Inhalers (containing drugs for treatment of cold and nasal congestion), Syrups lozenges, pills and tablets for cough, cold or sore throat.
  • 20. • Schedule L :- • Omitted Schedule L • Good Laboratory Practices and requirements of premises and equipments, Chemicals & Reagents, etc. Schedule M This Schedule includes Good Manufacturing Practices and requirements of premises, plant and equipment for manufacture of pharmaceutical products. ■ Part 1 :-Good Manufacturing Practices for premises and materials.  Part 2 :- Requirements of Plant and equipments
  • 21.  M- I:- Prescribes in detail requirements of factory premises for the manufacture of Homeopathic drugs.  M- II:- Prescribes requirements of factory premises for manufacture of cosmetics.  M- III:- Prescribes requirements of factory premises for manufacture of medical devices.
  • 22. • Schedule N List of minimum equipment for the efficient running of a pharmacy Gives directions to Pharmacies regarding:- a) Entrance of Pharmacy b) b) Premises c) c) Furniture & Apparatus d) d) General Provisions. Schedule O Deals with the provisions applicable to disinfectant fluids. • Part 1:- Provisions applicable to black and white fluids Part 2:- Provisions applicable to Other Disinfectants.
  • 23. Schedule P • It deals with life period of drug and the conditions of the storage of drugs. • Period in months (unless otherwise specified) between date of manufacture and date of expiry • ampicillin- stable for 36 month and store in cool place • Schedule P1 • specifies the pack size of certain drugs • Aspirin (Low Dose) Tablets 14 Tabs per pack.
  • 24. • Schedule Q • Gives the list of dyes, colors and pigments permitted to be used in cosmetics and soaps. • No drug should contain a colors other than specified by the Bureau of Indian Standards below : (1) Natural Colors:- Carotene, Chlorophyll, Red Oxide of Iron, Yellow Oxide of Iron, Titanium Di-oxide, Black Oxide of iron (2) Artificial Colors:-Caramel (3) Coal Tar Colors
  • 25. • Schedule R • Standards for mechanical contraceptives. • Eg. Cu-T, etc • Label contain:- – The date of manufacture. • – The date up to which the contraceptive is expected to retain its properties. Schedule R1 • Standards for medical devices. The following medical device shall conform to the Indian Standards specification laid down from time to time by the Bureau of Indian Standards: - 1. Sterile Disposable Perfusion sets for single use only 2. Sterile Disposable Hypodermic Syringes for single use only 3. Sterile Disposable Hypodermic Needles for single use only
  • 26. Schedule S  Prescribes Standard for Cosmetics  The following cosmetics in finished form should conform to the specifications laid down from time to time by the Bureau of Indian Standards (BIS). Skin Powders , Tooth Powder, Toothpaste ,Shaving Creams, Hair Creams.
  • 27. Schedule T  Lays down the Good Manufacturing Practices for Ayurvedic, Siddha and Unani Medicines  PART I:- Good manufacturing practices.  PART II:- List of recommended machinery, equipment and minimum manufacturing premises required for the manufacture of various categories of ayurvedic, siddha system of medicines.
  • 28. Schedule U & U1 • Gives the particulars to be shown in manufacturing records. • Gives the particulars to be recorded of raw materials. • Gives the particulars to be recorded in analytical records. • The records or registers shall be retained for a period of 5 years for Drugs & 3 years for Cosmetics from the date of manufacture Schedule V • Give details of standards for patent and proprietary medicines.
  • 29. Schedule W  Inserted as per G.O.I in 1981 and deleted IN 2000.  Gives the name of the drugs which shall be marketed under generic names only.  Its label contain the Names and quantities of active ingredients.
  • 30. • Schedule X • Contains list of narcotic drugs and psychotropic substance. • Have a warning mentioned on a label „Schedule X drug‟ - Warning : to be sold on retail on prescription of a RMP only. • The label will also have a symbol „NRx‟ in red & conspicuously displayed on the top left corner. • After dispending the drug the pharmacist must Stamp & retain the prescription for 2 years. • Maintain & record purchase & sale of the drug and preserve it for a period of 2 years from the date of transactions. • All the regulations of Schedule H apply. The drugs must be kept under lock and key. • Examples of few drugs under schedule X :- Phencyclidine, Secobarbital, Amobarbital, Amphetamines, Glutethimide, Methylphenidate, etc.
  • 31. Schedule Y • This Schedule includes requirements and guidelines for permission to import and / or manufacture of new drugs for sale or to undertake clinical trials It include: • Application for permission • Clinical trial:-  Approval for trial  Responsibilities of sponsor, investigator, Ethics Committee  Phases I, II, III, IV  Studies in special population like Geriatric, Pediatric and Pregnant/ Nursing women  Post Marketing Surveillance